IPO registrations (S-1, F-1) · Registrants
TriSalus Life Sciences, Inc.
- SEC CIK
- 1826667 · filings on EDGAR ↗
- Former names
- MedTech Acquisition Corp (2020–2023); MedTech Acquisition Corporation (2020–2020)
- Registration
- Form S-1, first filed 2020-11-30, last 2024-06-14; 4 initial registrations, 4 amendments
- Outcome
- Final prospectus filed 2020-12-21; declared effective 2020-12-17
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 6272 WEST 91ST AVENUE, Westminster, CO 80031
- EIN
- 85-3009869
- Ticker
- TLSI, TLSIW (Nasdaq, Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- TriSalus Life Sciences, Inc. on the corporate pages
Offering terms
- Final price
- $10.00 per share (424B4 filed 2020-12-21, an initial public offering)
- Gross proceeds
- $220,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol MTAC
- Lead underwriters
- Raymond James (22,000,000 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: TriSalus Life Sciences, Inc. Fuzzy (name and state)
- Business registration: TriSalus Life Sciences, Inc. Fuzzy (name and state)
- Business registration: TRISALUS LIFE SCIENCES, INC. Fuzzy (name and state)
- Business registration: TRISALUS LIFE SCIENCES, INC. Fuzzy (name and state)
- Business registration: TRISALUS LIFE SCIENCES, INC. Fuzzy (name and state)
- Business registration: TRISALUS LIFE SCIENCES, INC. Fuzzy (name and state)
- Business registration: TRISALUS LIFE SCIENCES, INC. Fuzzy (name and state)
- Federal award recipient: TRISALUS LIFE SCIENCES, INC. Fuzzy (name and state)
- Form D issuer: TriSalus Life Sciences, Inc. EXACT (CIK (EXACT))
- Lobbying client: TRISALUS LIFE SCIENCES Fuzzy (name and state)
- Lobbying client: TRISALUS LIFE SCIENCES Fuzzy (name and state)
- Lobbying client: TRISALUS LIFE SCIENCES Fuzzy (name and state)
- SEC filer: MedTech Acquisition Corp EXACT (CIK (EXACT))
- Person page: Christopher C Dewey Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner))
- Person page: David J Matlin Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 27
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-11-30 | S-1 | S-1 (registration) | MedTech Acquisition Corp | 0001104659-20-130568 ↗ |
| 2020-12-09 | S-1/A | S-1/A (amendment) | MedTech Acquisition Corp | 0001104659-20-133725 ↗ |
| 2020-12-17 | S-1MEF | S-1MEF (added securities) | MedTech Acquisition Corp | 0001104659-20-137066 ↗ |
| 2020-12-17 | EFFECT | EFFECT (declared effective) | MedTech Acquisition Corp | 9999999995-20-003567 ↗ |
| 2020-12-21 | 424B4 | 424B4 (final prospectus) | MedTech Acquisition Corp | 0001104659-20-138083 ↗ |
| 2023-07-18 | EFFECT | EFFECT (declared effective) | MedTech Acquisition Corp | 9999999995-23-002118 ↗ |
| 2023-08-31 | S-1 | S-1 (registration) | TriSalus Life Sciences, Inc. | 0001104659-23-097317 ↗ |
| 2023-09-01 | S-1/A | S-1/A (amendment) | TriSalus Life Sciences, Inc. | 0001104659-23-097801 ↗ |
| 2023-10-19 | S-1/A | S-1/A (amendment) | TriSalus Life Sciences, Inc. | 0001104659-23-109964 ↗ |
| 2023-12-15 | S-1/A | S-1/A (amendment) | TriSalus Life Sciences, Inc. | 0001104659-23-126113 ↗ |
| 2023-12-15 | S-1 | S-1 (registration) | TriSalus Life Sciences, Inc. | 0001104659-23-126397 ↗ |
| 2023-12-26 | EFFECT | EFFECT (declared effective) | TriSalus Life Sciences, Inc. | 9999999995-23-003739 ↗ |
| 2023-12-26 | EFFECT | EFFECT (declared effective) | TriSalus Life Sciences, Inc. | 9999999995-23-003748 ↗ |
| 2024-04-24 | EFFECT | EFFECT (declared effective) | TriSalus Life Sciences, Inc. | 9999999995-24-001098 ↗ |
| 2024-04-24 | EFFECT | EFFECT (declared effective) | TriSalus Life Sciences, Inc. | 9999999995-24-001100 ↗ |
| 2024-06-14 | S-1 | S-1 (registration) | TriSalus Life Sciences, Inc. | 0001104659-24-071480 ↗ |
| 2024-06-21 | EFFECT | EFFECT (declared effective) | TriSalus Life Sciences, Inc. | 9999999995-24-001917 ↗ |
| 2024-06-25 | EFFECT | EFFECT (declared effective) | TriSalus Life Sciences, Inc. | 9999999995-24-001946 ↗ |
| 2024-11-08 | EFFECT | EFFECT (declared effective) | TriSalus Life Sciences, Inc. | 9999999995-24-003409 ↗ |
| 2024-11-08 | EFFECT | EFFECT (declared effective) | TriSalus Life Sciences, Inc. | 9999999995-24-003411 ↗ |
| 2024-11-08 | EFFECT | EFFECT (declared effective) | TriSalus Life Sciences, Inc. | 9999999995-24-003417 ↗ |
| 2024-11-08 | EFFECT | EFFECT (declared effective) | TriSalus Life Sciences, Inc. | 9999999995-24-003432 ↗ |
| 2025-05-02 | EFFECT | EFFECT (declared effective) | TriSalus Life Sciences, Inc. | 9999999995-25-001395 ↗ |
| 2025-05-30 | EFFECT | EFFECT (declared effective) | TriSalus Life Sciences, Inc. | 9999999995-25-001792 ↗ |
| 2025-06-11 | EFFECT | EFFECT (declared effective) | TriSalus Life Sciences, Inc. | 9999999995-25-001892 ↗ |
| 2025-07-22 | EFFECT | EFFECT (declared effective) | TriSalus Life Sciences, Inc. | 9999999995-25-002311 ↗ |
| 2025-12-04 | EFFECT | EFFECT (declared effective) | TriSalus Life Sciences, Inc. | 9999999995-25-003539 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-12-09 | S-1/A | registration statement | $10.00 | - | $200,000,000 | Nasdaq MTAC | 1 | primary document; price sentence, proceeds table, cover names 1 | document ↗ | |
| 2020-12-21 | 424B4 | final prospectus | $10.00 | - | $220,000,000 | Nasdaq MTAC | 1 | primary document; price sentence, proceeds table, underwriting table 1, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Delevic Ivan | Director | 1 | 2020 | ||
| Dewey Christopher C | Director,Officer,TenPercentOwner; TenPercentOwner | Chief Executive Officer | 3 | 2020–2023 | person page Fuzzy |
| Ferre Maurice R | Director | 1 | 2020 | ||
| Karti Karim | Director | 1 | 2020 | ||
| MATLIN DAVID J | Director; Director,Officer,TenPercentOwner; TenPercentOwner | Chief Financial Officer | 10 | 2020–2026 | person page Fuzzy |
| MedTech Acquisition Sponsor LLC | TenPercentOwner | 3 | 2020–2023 | ||
| Roche Martin William | Director | 1 | 2020 | ||
| None | Officer | Chief Admin Officer and Sec. | 1 | 2020 | |
| Thaure Thierry B. | Director | 1 | 2021 | ||
| Aguero Manuel | Director | 1 | 2021 | ||
| TREADWELL DAVID L | Director | 1 | 2021 | ||
| Magnetar Capital Partners LP | TenPercentOwner | 2 | 2022–2023 | ||
| Magnetar Financial LLC | TenPercentOwner | 2 | 2022–2023 | ||
| Snyderman David J. | TenPercentOwner | 2 | 2022–2023 | ||
| Supernova Management LLC | TenPercentOwner | 2 | 2022–2023 | ||
| Alecxih James | Officer | President, Device Technology | 1 | 2023 | |
| Cox Bryan F. | Officer | Chief of Research; CHIEF OF RESEARCH; Chief Scientific & Manufact.; CHIEF SCIENTIFIC & MANUFACT. | 9 | 2023–2026 | |
| Desai Arjun JJ | Director | 6 | 2023–2025 | ||
| Frankenius Equity AB | TenPercentOwner | 4 | 2023–2026 | ||
| HICKS KERRY R | Director | 5 | 2023–2026 | ||
| Katz Steven C | Officer | Chief Medical Officer; CHIEF MEDICAL OFFICER | 3 | 2023–2024 | |
| Marshak Richard | Officer | Chief Commercial Officer; Sr.VP, Corp. Dev. & Strategy; SR.VP, CORP. DEV. & STRATEGY | 13 | 2023–2026 | |
| Martin George Kelly | Director | 5 | 2023–2024 | ||
| Murphy Sean | Director; Director,Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER; Chief Manuf, Strategy&Bus Dev. | 8 | 2023–2025 | |
| Singhal Anil K. | Director | 3 | 2023–2024 | ||
| Stevens Jennifer | Officer | Chief Regulatory Officer; CHIEF REGULATORY OFFICER | 8 | 2023–2026 | |
| VON ESCHENBACH ANDREW C. | Director | 4 | 2023–2024 | ||
| Wahlstrom Mats | Director; Director,TenPercentOwner | 10 | 2023–2026 | ||
| Szela Mary T | Director,Officer | CEO and President; CEO AND PRESIDENT | 14 | 2023–2026 | |
| Devlin Jodi | Officer | Chief of Clinical Operations; Chief of COMMERC. OPERATIONS; PRESIDENT, COMMERC. OPERATIONS; President, Therapeutics | 8 | 2023–2026 | |
| Hyveled Liselotte | Director | 4 | 2024–2025 | ||
| Young James Emmett | Officer | Chief Financial Officer | 5 | 2025 | |
| Gordon Gary B. | Director | 6 | 2025–2026 | ||
| Valle William | Director | 5 | 2025–2026 | ||
| Patience David | Officer | Chief Financial Officer | 7 | 2025–2026 | |
| Stansky Michael P | Director | 5 | 2026 | ||
| Marshall Richard Henry | Officer | Chief Medical Officer | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2025-05-08 | TriSalus Life Sciences, Inc. | Biotechnology | $22,000,000 | $22,000,000 | 24 | 1 |
| 2024-12-30 | TriSalus Life Sciences, Inc. | Biotechnology | $999,984 | $999,984 | 6 | 1 |
| 2023-06-22 | MedTech Acquisition Corp | Other Health Care | $50,000,000 | $17,855,020 | 17 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | TriSalus Life Sciences, Inc. | CO | State business registries | name and state |
| Business registration | TriSalus Life Sciences, Inc. | CO | State business registries | name and state |
| Business registration | TRISALUS LIFE SCIENCES, INC. | CO | State business registries | name and state |
| Business registration | TRISALUS LIFE SCIENCES, INC. | CO | State business registries | name and state |
| Business registration | TRISALUS LIFE SCIENCES, INC. | CO | State business registries | name and state |
| Business registration | TRISALUS LIFE SCIENCES, INC. | CO | State business registries | name and state |
| Business registration | TRISALUS LIFE SCIENCES, INC. | CO | State business registries | name and state |
| Plan sponsor | TRISALUS LIFE SCIENCES, INC. | CO | Form 5500 (employee benefit plans) | name and state |
| Federal award recipient | TRISALUS LIFE SCIENCES, INC. | CO | Federal spending (USAspending) | name and state |
| Form D issuer | TriSalus Life Sciences, Inc. | CO | Form D private offerings | CIK (EXACT) |
| Form D issuer | TriSalus Life Sciences, Inc. | CO | Form D private offerings | name and state |
| Lobbying client | TRISALUS LIFE SCIENCES | CO | Federal lobbying (LDA) | name and state |
| Lobbying client | TRISALUS LIFE SCIENCES | CO | Federal lobbying (LDA) | name and state |
| Lobbying client | TRISALUS LIFE SCIENCES | CO | Federal lobbying (LDA) | name and state |
| Paying company | TriSalus Life Sciences, Inc. | CO | Open Payments (drug and device company payments) | name and state |
| Patent assignee | TriSalus Life Sciences, Inc. | CO | Patents (USPTO) | name and state |
| SEC filer | TriSalus Life Sciences, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | TriSalus Life Sciences, Inc. | CO | Trademarks (USPTO) | name and state |
| Person page | Christopher C Dewey | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner) | |
| Person page | David J Matlin | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, CO first:
- HEALTHETECH INC CO
- Sonoma Pharmaceuticals, Inc. CO
- Paragon 28, Inc. CO
- Vivos Therapeutics, Inc. CO
- Assure Holdings Corp. CO
- SeaStar Medical Holding Corp CO
- FAMILY OFFICE OF AMERICA, INC. CO
- ENCISION INC CO
- SWISSRAY INTERNATIONAL INC NY
- FUSION MEDICAL TECHNOLOGIES INC CA
In other datasets, the same topic (Technology) in CO:
- Form D issuer: 30dB, Inc. (Form D private offerings)
- Lobbying client: 360NETWORKS (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology